Kelly Bosak | Stem Cell Research | Best Researcher Award

Dr. Kelly Bosak | Stem Cell Research | Best Researcher Award

University of Kansas Medical Center | United States

Dr. Kelly A. Bosak, PhD, APRN, ANP-BC, FHFSA, is a tenured Associate Professor at the University of Kansas Medical Center and a nationally recognized expert in heart failure care, nursing science, and implementation research. With a strong background in advanced practice nursing and nursing administration, Dr. Bosak has made significant contributions to interdisciplinary research focused on improving clinical outcomes in cardiology, rural health, and chronic disease management. Her peer-reviewed work spans high-impact journals such as The Journal of Cardiac Failure, Implementation Science, and The Journal for Nurse Practitioners, reflecting her leadership in both clinical practice and academic scholarship. Dr. Bosak has authored or co-authored over 30 peer-reviewed publications, with a Scopus h-index of 10, over 450 citations, and 32 documents indexed in major databases. She has played a pivotal role in national reports from the Heart Failure Society of America and led multiple implementation science projects aimed at integrating evidence-based interventions into routine care. Her current research emphasizes digital health innovation and workforce development in underserved communities. Dr. Bosak’s interdisciplinary collaborations and translational research continue to shape evidence-based practice and policy in cardiovascular nursing and advanced practice nursing education.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Return on Investment of a Nurse Practitioner Fellowship Program”

  • “Interprofessional Education for Improving Workforce Capacity to Treat COPD and Long COVID in Rural Communities”

  • “Shared Decision Making for the Pulmonary Artery Monitoring Device for Patients with Heart Failure”

  • “Implementation of a SmartPhrase for Exercise in the Electronic Health Record for Individuals with Heart Failure”

  • “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project”

  • “Team Science”

  • “Ceramides as Novel Biomarkers of Cardiometabolic Conditions”

  • “Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America”

  • “Heart Failure Epidemiology and Outcomes Statistics, A Report of the Heart Failure Society of America”

  • “Implementation Mapping and Concept Mapping to Explore Guideline Implementation in the Heart Failure Clinic”

  • “Coordinating Resources for a Hybrid Effectiveness and Implementation Trial Across an Integrated Digital Network for Heart Failure”

  • “Creating a Standardized Approach to Program Evaluation in a Magnet Recognized Pediatric Hospital System”

 

 

 

Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Amr Hanbali | King Faisal Specialist Hospital & Research Center | Saudi Arabia

Dr. Amr AlHanbali is a dual-certified Hematology and Oncology consultant with over 18 years of experience in malignant and benign hematological conditions. Based at King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia, he specializes in hematologic malignancies and stem cell transplantation. Dr. AlHanbali previously served as a senior staff physician and Associate Fellowship Program Director at Henry Ford Health System in Detroit, Michigan. Recognized for his academic involvement, he holds teaching appointments at Wayne State University and Alfaisal University. Known for his dedication to clinical mentorship, he has trained numerous medical students, residents, and fellows. He is actively involved in research and is a member of several prestigious medical organizations including the American Society of Hematology and American Society of Clinical Oncology. With expertise ranging from bone marrow procedures to managing complex hematologic disorders, Dr. AlHanbali is a respected leader in the field of hematology and stem cell transplantation.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Research Contribution

    • Over 17 peer-reviewed publications, including impactful case reports, national guidelines, and original research in hematology, oncology, and stem cell transplantation.

    • Active contributor to national guidelines on multiple myeloma, reflecting leadership in shaping national healthcare standards in KSA.

  2. Dual Academic and Clinical Roles

    • Combines academic excellence (as faculty at Wayne State University and Alfaisal University) with hands-on clinical expertise at a premier institution (King Faisal Specialist Hospital & Research Center).

  3. Innovative Focus in Hematology and Transplantation

    • Research into underexplored areas such as hepatitis B reactivation post-rituximab, genetic donor match outcomes, and therapies for AL amyloidosis.

  4. International Exposure and Leadership

    • Experience across the U.S. and Saudi Arabia, influencing programs in both systems.

    • Played a key role in training and selecting future hematology-oncology fellows in the U.S.

  5. Mentorship and Capacity Building

    • Mentored numerous trainees, enhancing research culture among younger clinicians.

Areas for Improvement:

  1. Higher Impact Publications Needed

    • While the volume and variety of research are commendable, more publications in top-tier journals (NEJM, Lancet, Blood, JCO) could boost citation impact and visibility.

  2. Research Grants and Collaborative Trials

    • Pursuing multicenter studies, international collaborations, or industry-sponsored clinical trials would further elevate his profile and expand research funding sources.

  3. Technological Innovation/Patents

    • Exploring biotech innovation, AI in diagnostics, or cellular therapy patents could position him among the top medical innovators.

Education:

Dr. Amr AlHanbali completed his Bachelor of Medicine and Surgery from the University of Jordan in 1999. He pursued medical training in the United States, starting with an internal medicine residency (2001–2004) at Henry Ford Health System, Detroit. He continued his specialization with a fellowship in Hematology and Oncology (2004–2007) at the same institution. During his training, he also undertook elective rotations in Pediatric Cardiology and Gastroenterology at the University of Texas Medical Branch, Galveston, further enriching his academic exposure. He is certified by the American Board of Internal Medicine in Internal Medicine (2004), Hematology (2007), and Oncology (2007). Dr. AlHanbali holds academic titles as a Clinical Assistant Professor at Wayne State University, Detroit, and Adjunct Associate Professor at Alfaisal University, Riyadh. His educational background reflects a strong foundation in internal medicine, with a deep focus on hematology and oncology, further supported by teaching and research excellence.

Experience:

Dr. AlHanbali’s clinical career spans over 18 years, currently serving as Hematology and Stem Cell Transplant Consultant at King Faisal Specialist Hospital & Research Center in Riyadh since 2013. Prior to this, he held multiple leadership roles at Henry Ford Health System, Detroit, including Senior Staff Physician and Associate Fellowship Program Director (2007–2013). His medical expertise covers the diagnosis and treatment of a wide range of hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myeloproliferative disorders. Dr. AlHanbali also has extensive experience in stem cell transplantation, intrathecal chemotherapy, and bone marrow biopsy. He has been instrumental in resident selection and curriculum development for fellowship programs in hematology and oncology. His work bridges clinical excellence with academic mentorship, guiding numerous trainees and junior physicians. In addition to patient care, he is involved in clinical guideline development and research, particularly in the field of multiple myeloma and transplant outcomes.

Research Focus:

Dr. Amr AlHanbali’s research is centered on hematologic malignancies, particularly multiple myeloma, lymphoma, leukemia, and stem cell transplantation. His work explores novel therapeutic approaches, transplant outcomes, disease progression, and treatment-related complications. He has contributed significantly to research on hepatitis B reactivation, chemotherapy-induced toxicities, and the protective role of comorbidities like diabetes in cancer metastasis. As an active member of the Saudi Myeloma Working Group, he has co-authored national guidelines for both newly diagnosed and relapsed/refractory multiple myeloma. His studies also examine health disparities in cancer care, including outcomes among African American populations and the impact of familial genetics in donor matches. With over a dozen peer-reviewed publications and case reports in high-impact journals, Dr. AlHanbali continues to push forward understanding in clinical hematology and oncology. He combines bedside insights with academic rigor to shape evidence-based practice and improve treatment outcomes in cancer and transplant medicine.

Publications Top Notes:

  1.  Mediastinal Hematoma With SVC Syndrome From A Central Venous Catheter Insertion – CHEST, 2003

  2.  Diabetes Has Protective Effect Against Metastasis in Non-Small Cell Lung Cancer – Arch Intern Med, 2007

  3.  Delayed Hepatitis B Viral Replication Post-Rituximab & Fludarabine in Waldenstrom Macroglobulinemia – Am J Hematol, 2007

  4.  Acute Pancreatitis Induced by Adult Precursor B-cell ALL – South Med J, 2007

  5.  Hypersensitivity Reaction of Mylotarg with Platelet Transfusion – Am J Health Syst Pharm, 2007

  6.  Incidence of Hepatitis B Reactivation after Rituximab Therapy – Am J Hematol, 2009

  7. Outcomes After Auto-SCT in African Americans with Multiple Myeloma – Bone Marrow Transplant, 2009

  8.  HER-2 Status May Change in Recurrent Breast Cancer – Cancer Research, 2009

  9.  Compartment Syndrome as Presentation of Chronic Myelogenous Leukemia – J Gen Intern Med, 2010

  10.  Use of Insulin and its Effect on Survival in NSCLC – J Clin Oncol, 2009

Conclusion:

Dr. Amr AlHanbali demonstrates a stellar blend of clinical expertise, research productivity, academic mentorship, and leadership in hematology and oncology. His research contributions have practical implications in areas such as multiple myeloma, leukemia, transplant immunology, and chemotherapy safety.

He is highly deserving of recognition and stands out as a top contender for a Best Researcher Award, particularly in the categories of clinical research excellence, translational hematology, and medical education integration with research.

ALINE TAKEJIMA | Tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA | tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA, pontificia universidade catolica do parana, Brazil

Dr. Aline Luri Takejima is a physician-scientist from Brazil, specializing in regenerative medicine and wound healing. She holds an MD and a PhD in Health Sciences from the Pontifical Catholic University of Paraná (PUCPR), where she currently conducts postdoctoral research. With a focus on biological therapies involving the amniotic membrane, Wharton’s jelly, and mononuclear stem cells, Dr. Takejima has published in multiple high-impact scientific journals. Her research aims to develop novel regenerative strategies to treat complex wounds and enhance tissue repair. As an active member of PUCPR’s Wound Healing Research Group and the Brazilian Society of Plastic Surgery, she combines scientific rigor with clinical insight to bridge bench-to-bedside innovation. Her academic contributions are guided by a translational approach, offering promising avenues for future clinical applications in tissue engineering.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Focused Research Excellence:
    Dr. Takejima’s work on biological scaffolds and stem cells in wound healing is both innovative and clinically relevant. Her studies using amniotic membrane, Wharton’s jelly, and bone marrow mononuclear cells show promising regenerative outcomes in preclinical models.

  2. Research Productivity:
    With 9 peer-reviewed journal articles in high-quality platforms (e.g., Biomedicines, Tissue Barriers, Annals of Biomedical Engineering), she demonstrates consistent academic output in her field.

  3. Translational Impact:
    Her research bridges basic science and clinical practice, aiming to provide regenerative solutions for patients with chronic wounds and cardiac damage.

  4. Collaborative Engagement:
    Active participation in a multidisciplinary wound healing research group, contributing to cross-functional scientific advancements.

  5. Recognition Potential:
    As a young, emerging woman researcher in biomedical sciences, she stands as a role model for future female scientists in Latin America and beyond.

🔧 Areas for Improvement:

  1. Intellectual Property & Innovation:
    No patents filed yet; transitioning her research into patentable therapies or commercial applications would increase its societal and economic impact.

  2. Leadership Roles:
    While active in research, taking on editorial or scientific leadership positions would enhance her academic visibility and influence.

  3. Internationalization:
    She would benefit from developing international collaborations or fellowships to diversify her research scope and increase global reach.

  4. Industry Engagement:
    Engaging in consultancy or biotech partnerships can further the translational impact of her regenerative strategies.

🎓 Education:

Dr. Takejima’s educational journey began with a Doctor of Medicine (MD) degree from the Pontifical Catholic University of Paraná (PUCPR), Brazil. Her passion for research led her to pursue a Doctorate (PhD) in Health Sciences/Medicine, also at PUCPR. Her doctoral thesis focused on the use of biologically active materials such as the amniotic membrane and stem cells to enhance wound healing. Throughout her academic training, she demonstrated a strong commitment to translational medicine by integrating basic science with clinical practice. During her PhD, she engaged in experimental models involving stem cell therapy and tissue engineering, which laid the groundwork for her current postdoctoral research. Her educational path reflects both depth and specialization in the biomedical sciences, particularly in regenerative medicine and cellular therapies.

💼 Experience:

Dr. Aline Takejima has over a decade of experience in medical and scientific fields, balancing her role as a physician with that of a postdoctoral researcher. Her clinical background informs her research, particularly in areas of wound healing and regenerative medicine. At PUCPR, she contributes to the Wound Healing Research Group, where she is involved in designing and conducting animal model studies to test the effects of biomaterials and stem cells. Her multidisciplinary research integrates immunology, histopathology, and molecular biology. With nine peer-reviewed publications and participation in collaborative research, she has become a respected contributor to the field. Though early in her research career, her trajectory shows a steady rise, marked by evidence-based outcomes and a commitment to innovation. Her goal is to bridge clinical challenges with regenerative solutions that can be implemented in real-world medical practice.

🔬 Research Focus:

Dr. Takejima’s research focuses on regenerative strategies for wound healing, utilizing biomaterials and stem cells. Her work primarily explores the application of amniotic membrane, Wharton’s jelly, and bone marrow-derived mononuclear stem cells in treating complex or chronic skin wounds. Using experimental models in rats and rabbits, she evaluates histological recovery, inflammation modulation, and tissue regeneration. A significant aspect of her research is understanding how these materials promote healing through paracrine effects rather than direct integration, offering a safer and scalable pathway to clinical application. Additionally, her work extends to cardiac and tracheal tissue repair, emphasizing the versatility of these regenerative approaches. The translational nature of her research bridges laboratory discoveries with potential bedside applications, positioning her at the forefront of cellular therapy and biomaterials science.

📚 Publications Top Notes:

  1. 🧠 Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in RatsJournal of Functional Biomaterials, 2025

  2. 🧫 The effects of decellularized amniotic membrane and Wharton’s jelly on the healing of experimental skin wounds in ratsTissue Barriers, 2025

  3. ❤️ Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function…Anais da Academia Brasileira de Ciências, 2024

  4. 🫁 Tracheal regeneration with acellular human amniotic membrane and 15d-PGJ2 nanoparticles in rabbitsAnais da Academia Brasileira de Ciências, 2023

  5. 🧬 Acellular Biomaterials + Autologous Stem Cells Improve Wound Healing via Paracrine EffectsBiomedicines, 2023

  6. 💉 Decellularized Amniotic Membrane Solubilized with Hyaluronic Acid in Wound HealingAnnals of Biomedical Engineering, 2022

  7. 🧪 Role of Mononuclear Stem Cells and Decellularized Amniotic Membrane in Skin WoundsTissue Barriers, 2022

  8. 🏥 Trauma hepático: epidemiologia de cinco anos…Revista do Colégio Brasileiro de Cirurgiões, 2008

🧾 Conclusion:

Dr. Aline Luri Takejima is an outstanding candidate for the Women Researcher Award. Her academic profile demonstrates a strong foundation in regenerative medicine with significant contributions to wound healing research. Her commitment to applying biological therapies in clinical contexts shows both depth and innovation. As a woman scientist in a competitive field, she exemplifies leadership, dedication, and potential. With further growth in global engagement and innovation strategy, Dr. Takejima is poised to become a future leader in regenerative biomedical research.

Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr. Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr. Priyanshu Mathur , SMS Medical College, Jaipur , India

Dr. Priyanshu Mathur is an esteemed expert in Pediatric Medicine and Genetics, serving as an Associate Professor at SMS Medical College, Jaipur, India. He is renowned for his pioneering work in rare diseases, neurometabolism, and newborn screening. With a robust academic background, Dr. Mathur holds an MD in Pediatrics, a PhD in Genetics (Honorary), and specialized training in clinical biochemical genetics and neurometabolism. He is actively involved in clinical research and education, focusing on inborn errors of metabolism and rare genetic disorders. Dr. Mathur’s leadership extends to founding India’s first Rare Diseases Registry and establishing a newborn screening lab. He has significantly impacted both clinical practice and academic spheres in India and abroad. He is an active member of various international networks and has contributed extensively to medical research and education, solidifying his position as a thought leader in pediatric genetics and rare diseases.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Priyanshu Mathur exhibits a profound commitment to advancing pediatric medicine, particularly in the fields of genetics, neurometabolism, and rare diseases. His extensive academic and clinical contributions make him an exceptional candidate for the Best Researcher Award. Below are the key strengths that highlight his qualifications:

  1. Educational Excellence:
    • Dr. Mathur’s advanced qualifications, including a Masters in Neurometabolism & Cell Biology from the University of Barcelona and a Fellowship in Clinical Biochemical Genetics & Newborn Screening in the USA, underscore his expertise in rare metabolic disorders and genetic diseases.
    • His honorary PhD in Genetics further exemplifies his contributions to genetic research and medicine.
  2. Research and Clinical Leadership:
    • He has been instrumental in establishing the first Indian Rare Diseases Registry, which has provided valuable insights into rare disease prevalence in India (www.rarediseasesregistryindia.com).
    • His work in newborn screening and biochemical genetics, including his leadership in starting the NBS lab at J K Lone hospital, Jaipur, demonstrates a significant impact on early detection and management of genetic disorders.
    • His role as a Principal Investigator (PI) in DBT and ICMR-approved research projects highlights his ability to lead national-level research initiatives.
  3. Publication Record and Recognition:
    • Dr. Mathur has contributed extensively to the scientific literature, with numerous original articles and case reports, often focusing on rare diseases, pediatric genetics, and metabolic disorders.
    • His published works, along with his contributions to textbooks such as Rare Diseases in Pediatrics, exemplify his thought leadership.
    • He is also actively involved in peer review, further demonstrating his academic credibility.
  4. Clinical and Teaching Experience:
    • With years of experience as an Associate Professor at SMS Medical College and as a consultant at J K Lone Hospital, Dr. Mathur has shown excellence in clinical practice and teaching.
    • He is deeply involved in mentoring postgraduate students, guiding them in the fields of genetics and pediatrics, and helping shape the next generation of medical professionals.
  5. National and International Impact:
    • Dr. Mathur’s expertise is internationally recognized, with participation as a speaker and panelist at various international summits, including NBS Virtual Summit and Emory University sessions.
    • His role as a national faculty member for IAP programs and his advisory positions with organizations such as the Rare Disease India Foundation further underscore his leadership.

Areas for Improvement:

  1. Expansion of Research Focus:
    • Although Dr. Mathur has made immense contributions in metabolic genetics and rare diseases, there is potential for further exploration into emerging areas such as gene therapy, CRISPR-based technologies, and personalized medicine.
    • Collaborating with multidisciplinary teams to explore integrative approaches to pediatric genetic disorders could enrich his research portfolio.
  2. Further International Collaboration:
    • Increasing international collaborations, particularly in the context of clinical trials and large-scale multicenter studies, could significantly enhance the global impact of his work. This could provide broader insights and validation of his findings across diverse populations.
  3. Public Outreach and Advocacy:
    • While his contributions to academia are remarkable, further emphasis on public outreach programs to raise awareness about rare diseases and genetic conditions could increase their visibility in India and beyond.
    • Engaging with patient advocacy groups could help bridge the gap between research and patient care.

Education:

Dr. Priyanshu Mathur’s educational journey showcases a deep commitment to advancing knowledge in pediatric medicine and genetics. He earned his MBBS in 2005 from Vijayanagar Institute of Medical Sciences, Bellary, Karnataka, India, where he secured the first rank. He completed his MD in Pediatrics in 2010 from Dr. S. N. Medical College, Jodhpur, Rajasthan, India. His academic pursuits include a Masters in Neurometabolism & Cell Biology for Clinicians from the University of Barcelona, Spain (2022-2024). Dr. Mathur also underwent a Fellowship in Metabolic Genetics and Newborn Screening in Atlanta, USA (2018-2019), strengthening his expertise in the diagnosis and management of genetic disorders. His honorary PhD in Genetics from IIU in 2021 further bolstered his academic stature. His education equips him with an exceptional foundation in clinical genetics, pediatrics, and research, allowing him to contribute meaningfully to the field of medical science.

Experience:

Dr. Priyanshu Mathur’s professional experience spans over a decade, making him a leader in pediatric medicine and genetics. He is currently an Associate Professor at SMS Medical College, Jaipur, where he teaches and mentors future medical professionals. Dr. Mathur’s clinical expertise is evident in his role at J K Lone Hospital, Jaipur, where he oversees the Rare Diseases Clinic and newborn screening services. His experience extends internationally, having worked as a visiting assistant professor in clinical biochemical genetics and newborn screening in Atlanta, USA. He is deeply involved in clinical research, particularly in the field of genetic disorders and rare diseases, and has contributed to several national and international research projects. Dr. Mathur’s teaching roles include guiding postgraduate students and being a faculty member for various national courses and workshops. His work in establishing the first Indian Rare Diseases Registry and newborn screening lab has had a transformative impact on Indian healthcare.

Awards and Honors:

Dr. Priyanshu Mathur has earned multiple prestigious awards throughout his career, recognizing his dedication to research, teaching, and clinical excellence. In 2021, he received an Honorary Doctorate (PhD) in Genetics from IIU for his outstanding contributions to genetics and pediatric medicine. He was awarded a Fellowship in Clinical Biochemical Genetics & Newborn Screening in 2019, marking his specialization in metabolic genetics. In the same year, he received the Outstanding Faculty Award from the Principal of SMS Medical College, Jaipur, for his exceptional contributions to education. Dr. Mathur was also honored with the “Dakshata Praman Patra” at SMS Medical College, Jaipur, in 2016. Earlier in his career, he won the Silver Medal for paper presentation at a State Pediatric Conference in 2009 and was recognized as the Best Outgoing Student at VIMS, Bellary, in 2005. His awards reflect his commitment to advancing medical science and improving healthcare delivery.

Research Focus:

Dr. Priyanshu Mathur’s research primarily focuses on rare diseases, metabolic disorders, and inborn errors of metabolism. He has significantly contributed to the establishment of India’s first Rare Diseases Registry, which provides crucial insights into the prevalence and management of rare genetic conditions in the Indian population. His work in neurometabolism and newborn screening has been groundbreaking, particularly in identifying genetic disorders early and enabling early interventions. Dr. Mathur’s research has expanded the understanding of metabolic genetic diseases and their clinical management, making a considerable impact on patient care. He has also been involved in various clinical trials to evaluate the safety and efficacy of treatments for rare diseases such as Duchenne Muscular Dystrophy and Fabry Disease. His research is not only aimed at better clinical outcomes but also at educating the medical community and raising awareness about rare and inherited disorders. His work continues to shape the landscape of pediatric genetics in India.

Publications Top Notes:

  1. Prevalence of obesity and overweight in private schools of Jaipur city in 11-17 year age group children 📊
  2. Correlation study of various factors with germinal matrix intraventricular hemorrhage in preterm neonates 👶
  3. Evaluation of nutritional & educational intervention as KAP and outcome of children with SAM in malnutrition treatment center 🍽️
  4. Chloroquine vs co-artemether in uncomplicated malaria 🦠
  5. Comparison of risk factors and early morbidity in late preterm neonates and term neonates ⚖️
  6. Prevalence of impaired glucose tolerance test and diabetes in overweight, obese and apparently healthy adolescents 🏫
  7. Prevalence of overweight and obesity amongst adolescents and identification of risk factors 🍔
  8. Assessment of parents and child’s attitude as barrier to dietary compliance in celiac disease 🍞
  9. Study on clinical presentations, risk factors and short term outcome of hemorrhagic disease of newborn 🩸
  10. Epidemiological study of HIV-AIDS in children of western Rajasthan 🌍

Conclusion:

Dr. Priyanshu Mathur’s dedication to advancing pediatric medicine through groundbreaking research in genetics and rare diseases, along with his leadership in newborn screening and education, positions him as an exemplary candidate for the Best Researcher Award. His clinical expertise, substantial publication record, and impact on both national and international healthcare systems demonstrate that he is not only a skilled researcher but also a pioneering figure in improving the lives of children affected by genetic and metabolic disorders. With continued expansion into new areas of research and further global collaborations, Dr. Mathur can continue to make an even greater impact on pediatric healthcare worldwide.